THE MAXIMISE STUDY

Completed

• Conditions: Chronic (systolic) heart failure; Cardiovascular - Coronary heart disease

• Registration Number: ACTRN12606000383561
• Lead Sponsor: In-house (Austin Hospital Medical Research Foundation) research funds of A/Prof David L. Hare

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2006-08-30
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

1. CHF with beta blocker therapy at less than half target dose requiring up-titration2. Left ventricular (LV) systolic dysfunction as documented by RNVG or echocardiography3. Written informed consent prior to enrolment.

Exclusion Criteria

1. Previously failed an up-titration of beta blocker in the previous six months2. Medically inappropriate for up-titration of beta blockers in a nurse supervised heart filaure titration clinic.

Study & Design

• Study Type: Interventional
• Study Design: Not specified